Combination of Astragaloside IV and Tetramethylpyrazine Promotes Angiogenesis via the MALAT1–CXCL12/CXCR4 Axis in Brain Endothelial Cells After Ischemic Injury
Medical Science Monitor · 2026
DOI: 10.12659/msm.953474 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Monitor, 2026. Verfasst von Guangya Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Psychology, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine (Shenzhen Traditional Chinese…. Hauptthemen laut MEDLINE: Saponins, Pyrazines, Triterpenes, Brain Ischemia. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Psychology, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine (Shenzhen Traditional Chinese Medicine Hospital), Shenzhen, Guangdong, China.
- Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Zitieren
APA
Li, G., Lu, Y., Huang, L., Zhu, J., Li, L., Li, P., Li, S., & Qin, X. (2026). Combination of Astragaloside IV and Tetramethylpyrazine Promotes Angiogenesis via the MALAT1–CXCL12/CXCR4 Axis in Brain Endothelial Cells After Ischemic Injury. Medical Science Monitor. https://doi.org/10.12659/msm.953474
Vancouver
Li G, Lu Y, Huang L, Zhu J, Li L, Li P, et al. Combination of Astragaloside IV and Tetramethylpyrazine Promotes Angiogenesis via the MALAT1–CXCL12/CXCR4 Axis in Brain Endothelial Cells After Ischemic Injury. Medical Science Monitor. 2026. doi:10.12659/msm.953474
BibTeX
@article{Li2026,
author = {Li, Guangya and Lu, Yunwei and Huang, Liuling and Zhu, Jingwen and Li, Liling and Li, Peize and Li, Shanshan and Qin, Xiude},
title = {Combination of Astragaloside IV and Tetramethylpyrazine Promotes Angiogenesis via the MALAT1–CXCL12/CXCR4 Axis in Brain Endothelial Cells After Ischemic Injury},
journal = {Medical Science Monitor},
year = {2026},
doi = {10.12659/msm.953474}
}
EUVIMED